Washington Trust Bank’s GSK GSK Stock Holding History

Washington Trust Bank’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-540	Closed	-$29K	–	339
2019 Q1	$29K	Buy	540 +49	+10%	+$2.45K	﹤0.01%	399
2018 Q4	$24K	Sell	491 -5	-1%	-$246	﹤0.01%	419
2018 Q3	$24K	Buy	496 +49	+11%	+$2.49K	﹤0.01%	462
2018 Q2	$23K	Hold	447	–	–	﹤0.01%	463
2018 Q1	$22K	Sell	447 -60	-12%	-$2.79K	﹤0.01%	502
2017 Q4	$23K	Sell	507 -2,340	-82%	-$108K	﹤0.01%	533
2017 Q3	$145K	Buy	2,847 +2,560	+892%	+$130K	0.02%	257
2017 Q2	$15K	Hold	287	–	–	﹤0.01%	512
2017 Q1	$15K	Sell	287 -800	-74%	-$40.6K	﹤0.01%	541
2016 Q4	$52K	Sell	1,087 -1,680	-61%	-$83K	0.01%	386
2016 Q3	$149K	Buy	2,767 +2,480	+864%	+$136K	0.04%	217
2016 Q2	$16K	Hold	287	–	–	﹤0.01%	516
2016 Q1	$15K	Sell	287 -672	-70%	-$33.5K	﹤0.01%	537
2015 Q4	$48K	Buy	959 +416	+77%	+$21.2K	0.01%	392
2015 Q3	$26K	Sell	543 -961	-64%	-$50K	0.01%	490
2015 Q2	$78K	Sell	1,504 -5,024	-77%	-$283K	0.02%	342
2015 Q1	$377K	Buy	6,528 +594	+10%	+$34.1K	0.09%	138
2014 Q4	$317K	Buy	5,934 +526	+10%	+$29.4K	0.08%	167
2014 Q3	$311K	Sell	5,408 -1,560	-22%	-$95.6K	0.1%	163
2014 Q2	$466K	Buy	6,968 +80	+1%	+$5.42K	0.09%	145
2014 Q1	$460K	Buy	+6,888	New	+$466K	0.1%	139

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Washington Trust Bank's GSK Position: Q2 2019 in Review

Washington Trust Bank sold out of GSK (GSK) in Q2 2019, closing a stake of 540 shares — an estimated $29K sold.

Washington Trust Bank first reported a position in GSK in Q1 2014 and held it in 21 quarters. The position peaked at $466K in Q2 2014. 804 funds tracked by Wall St. Rank hold GSK as of Q2 2019.

Washington Trust Bank reported no remaining GSK position as of Q2 2019 after selling out during the quarter.
Washington Trust Bank sold 540 GSK shares in Q2 2019, an estimated $29K.
Washington Trust Bank first reported a position in GSK in Q1 2014 and held it in 21 quarters.
Washington Trust Bank's GSK position peaked at $466K in Q2 2014.
804 funds tracked by Wall St. Rank held GSK as of Q2 2019.

Based on Washington Trust Bank's 13F filing for Q2 2019, filed 26 Jul 2019.